Quantitative Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-74,969
| Closed | -$3.81M | – | 503 |
|
|
2025
Q4 | $3.81M | Sell |
74,969
-123,730
| -62% | -$6.33M | 0.37% | 54 |
|
|
2025
Q3 | $11M | Buy |
+198,699
| New | +$11.6M | 1.53% | 15 |
|
|
2025
Q2 | – | Sell |
-207,314
| Closed | -$14.4M | – | 422 |
|
|
2025
Q1 | $14.4M | Buy |
207,314
+159,638
| +335% | +$13.2M | 1.32% | 13 |
|
|
2024
Q4 | $4.1M | Buy |
+47,676
| New | +$5.16M | 0.31% | 74 |
|
|
2024
Q1 | – | Sell |
-10,866
| Closed | -$1.12M | – | 342 |
|
|
2023
Q4 | $1.12M | Buy |
+10,866
| New | +$1.07M | 0.06% | 245 |
|
|
2021
Q3 | – | Sell |
-25,662
| Closed | -$1.07M | – | 515 |
|
|
2021
Q2 | $1.07M | Buy |
+25,662
| New | +$995K | 0.1% | 184 |
|
|
2020
Q4 | – | Sell |
-55,580
| Closed | -$1.93M | – | 561 |
|
|
2020
Q3 | $1.93M | Buy |
+55,580
| New | +$1.85M | 0.17% | 116 |
|
|
2020
Q1 | – | Sell |
-158,790
| Closed | -$4.59M | – | 735 |
|
|
2019
Q4 | $4.59M | Sell |
158,790
-69,568
| -30% | -$1.93M | 0.14% | 171 |
|
|
2019
Q3 | $5.9M | Sell |
228,358
-41,744
| -15% | -$1.06M | 0.32% | 89 |
|
|
2019
Q2 | $6.89M | Buy |
270,102
+203,902
| +308% | +$5.04M | 0.27% | 97 |
|
|
2019
Q1 | $1.73M | Buy |
+66,200
| New | +$1.63M | 0.1% | 268 |
|
|
2018
Q4 | – | Sell |
-14,600
| Closed | -$344K | – | 753 |
|
|
2018
Q3 | $344K | Sell |
14,600
-136,000
| -90% | -$3.32M | 0.01% | 493 |
|
|
2018
Q2 | $3.47M | Buy |
150,600
+130,600
| +653% | +$3.1M | 0.07% | 260 |
|
|
2018
Q1 | $492K | Buy |
+20,000
| New | +$525K | 0.01% | 654 |
|
|
2017
Q1 | – | Sell |
-46,400
| Closed | -$831K | – | 833 |
|
|
2016
Q4 | $831K | Buy |
+46,400
| New | +$841K | 0.02% | 636 |
|
|
2016
Q2 | – | Sell |
-185,800
| Closed | -$5.03M | – | 871 |
|
|
2016
Q1 | $5.03M | Buy |
185,800
+91,800
| +98% | +$2.46M | 0.24% | 97 |
|
|
2015
Q4 | $2.73M | Buy |
94,000
+71,400
| +316% | +$1.98M | 0.17% | 160 |
|
|
2015
Q3 | $612K | Buy |
22,600
+3,600
| +19% | +$102K | 0.05% | 401 |
|
|
2015
Q2 | $520K | Buy |
+19,000
| New | +$534K | 0.08% | 224 |
|
|
2014
Q4 | – | Sell |
-24,000
| Closed | -$571K | – | 550 |
|
|
2014
Q3 | $571K | Buy |
24,000
+8,000
| +50% | +$184K | 0.11% | 163 |
|
|
2014
Q2 | $369K | Sell |
16,000
-23,000
| -59% | -$508K | 0.07% | 285 |
|
|
2014
Q1 | $890K | Buy |
39,000
+7,000
| +22% | +$149K | 0.04% | 262 |
|
|
2013
Q4 | $591K | Buy |
32,000
+20,000
| +167% | +$349K | 0.06% | 297 |
|
|
2013
Q3 | $203K | Buy |
+12,000
| New | +$202K | 0.02% | 505 |
|
Other funds holding NVO
DAM
F
Quantitative Investment Management's NVO Position: Q1 2026 in Review
Quantitative Investment Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 74,969 shares — an estimated $3.81M sold.
Quantitative Investment Management first reported a position in NVO in Q3 2013 and held it in 24 quarters. The position peaked at $14.4M in Q1 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Quantitative Investment Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Quantitative Investment Management sold 74,969 Novo Nordisk shares in Q1 2026, an estimated $3.81M.
- Quantitative Investment Management first reported a position in Novo Nordisk in Q3 2013 and held it in 24 quarters.
- Quantitative Investment Management's Novo Nordisk position peaked at $14.4M in Q1 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.